Denis Chem Lab Ltd (DENISCHEM) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Denis Chem Lab Ltd on NSE and BSE, with an AI summary of each filing.
Unaudited Financial Results for the Quarter ended 30th September, 2026 along with Limited Review Report thereon.
Financial Result · 04 Nov 2026, 8:36 pm
Denis Chem Lab Reports Q2 FY27 Net Loss on Declining Revenues Denis Chem Lab reported standalone revenue from operations of Rs.3,934.99 lakh for the quarter ended 30th Sep'26, declining 14.77% YoY from Rs.4,617.13 lakh and 10.56% QoQ from Rs.4,399.67 lakh. The company slipped into a net loss of Rs.57.19 lakh compared to a net profit of Rs.221.25 lakh in Q2 FY26 and Rs.204.52 lakh in Q1 FY27, generating a negative EPS of Rs.0.41. For H1 FY27, revenue reached Rs.8,334.66 lakh with net profit at Rs.147.32 lakh. Shareholders approved a 25% dividend (Rs.2.50 per share) totaling Rs.346.91 lakh.
The Board of Directors in their meeting held today, have taken on record the Un-audited Financial Results for the Quarter ended on 30th September, 2026.
Outcome · 04 Nov 2026, 8:27 pm
Denis Chem Lab Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 3,935 (-14.8% YoY | -10.6% QoQ) ■ EBITDA: 70.2 (-83.5% YoY | -81.7% QoQ) ■ EBITDA Margin (%): 1.8 (-745 bps YoY | -692 bps QoQ) ■ PAT: -57.2 (Profit to Loss YoY | Profit to Loss QoQ) ■ EPS (INR): -0.41 (Profit to Loss YoY | Profit to Loss QoQ)
Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....
Intimation · 04 Nov 2026, 5:30 am
Denis Chem Lab Board to Consider Q2 FY27 Results on 4th Nov'26 Denis Chem Lab Limited has scheduled a Board of Directors meeting on 4th Nov'26 to consider and approve the company's unaudited financial results for the quarter ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for designated persons will remain closed until 48 hours after the declaration of the financial results.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for VS Holding B V
Acquisition/ Disposal of Shares · 16 Oct 2026, 11:05 pm
VS Holding BV Reduces Stake in Denis Chem Lab to 14.41% via Open Market Non-promoter entity VS Holding BV offloaded 284,447 equity shares, representing a 2.05% stake, in Denis Chem Lab Limited via open market transactions executed across Sep'26 and Oct'26 (up to 16th Oct'26). Following the disposal, VS Holding BV's stake decreased from 2,284,335 shares (16.46% voting capital) to 1,999,888 shares (14.41% voting capital). The total equity base of Denis Chem Lab remains unchanged at 13,876,668 shares (face value Rs. 10 each).
With reference to our earlier intimation vide letter dated 29th July, 2026, please note that in the Company''s Annual General Meeting held today i.e. on 25th September, 2026, through VC/ ....
Change in Management · 25 Sept 2026, 9:49 pm
With reference to our earlier intimation vide letter dated 29th July, 2026, please note that in the Company's Annual General Meeting held today i.e. on 25th September, 2026, through VC/ ....
Change in Management · 25 Sept 2026, 9:29 pm
With reference to our letter dated 29th July, 2026, this is to inform you that the Shareholders/ Members in their 45th Annual General Meeting (AGM) held on Friday, the 25th September, 2026 ....
Annual General Meeting · 25 Sept 2026, 9:25 pm
Declaration of Results of Resolutions passed at the 45th Annual General Meeting and Submission of Scrutineer''s Report.
Annual General Meeting · 25 Sept 2026, 9:20 pm
Declaration of Results of Resolutions passed at the 45th Annual General Meeting and Submission of Scrutineer''s Report.
Annual General Meeting · 25 Sept 2026, 9:17 pm
We are enclosing herewith copy of the Proceedings of the 45th Annual General Meeting of the Company held on 25th September, 2026 through Video Conferencing (''''VC'''')/ Other Audio-Visual ....
Annual General Meeting · 25 Sept 2026, 9:06 pm
We are enclosing herewith copy of the Proceedings of the 45th Annual General Meeting of the Company held on 25th September, 2026 through Video Conferencing (''''VC'''')/ Other Audio-Visual ....
Audio / Video · 25 Sept 2026, 8:59 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for VS Holdings BV
Acquisition/ Disposal of Shares · 04 Sept 2026, 10:13 pm
VS Holding BV Trims Stake in Denis Chem Lab to 16.46% via Open Market Non-promoter entity VS Holding BV reduced its stake in Denis Chem Lab Limited from 18.68% (2,591,929 shares) to 16.46% (2,284,335 shares). The disposal of a 2.22% equity stake (307,594 shares) was executed via open-market transactions between Jul'26 and 4th Sep'26. Following the sale, Denis Chem Lab's total voting capital remains unchanged at Rs 13.88 cr, comprising 13,876,668 equity shares of Rs 10 each.
Notice Of 45th AGM Along With Annual Report 2025-26
Annual General Meeting · 18 Aug 2026, 10:28 pm
Submission of Notice of 45th AGM along with Annual Report 2025-26.
Annual General Meeting · 18 Aug 2026, 10:25 pm
We are enclosing herewith Annual Report for FY 2025-26 along with Notice of 45th Annual General Meeting of the members of the Company.
Others (Uncategorized) · 18 Aug 2026, 10:20 pm
The Board of Directors in their meeting held today, have taken on record the Unaudited Financial Results for the quarter ended on 30th June, 2026. We are enclosing herewith copy of the ....
Financial Result · 13 Aug 2026, 7:29 pm
Denis Chem Lab Q1 FY27 Net Profit Declines YoY on Stable Revenue Denis Chem Lab reported a 17.4% YoY decline in net profit to ₹204.52 lakh for the quarter ended 30th Jun'26, down from ₹247.50 lakh in the prior year. Sequentially, profit grew significantly by 411% QoQ. Revenue from operations remained stable at ₹4,399.67 lakh, a modest 1.7% YoY increase. Total expenses rose 3.8% YoY to ₹4,180.30 lakh, impacting profitability. Basic EPS for the quarter was ₹1.47, compared to ₹1.78 in Q1 FY26 and ₹0.29 in the preceding quarter.
The Board of Directors in their meeting held today, have taken on record the Unaudited Financial Results for the quarter ended on 30th June, 2026. We are enclosing herewith copy of the ....
Outcome · 13 Aug 2026, 7:16 pm
Denis Chem Lab Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 4,400 (+1.7% YoY | -5.9% QoQ) ■ EBITDA: 383 (-20.4% YoY | +50.6% QoQ) ■ EBITDA Margin (%): 8.7 (-241 bps YoY | +327 bps QoQ) ■ PAT: 205 (-17.4% YoY | +411.2% QoQ) ■ EPS (INR): 1.47 (-17.4% YoY | +406.9% QoQ)
Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....
Intimation · 13 Aug 2026, 5:30 am
Denis Chem Lab Board Meeting for Q1 FY27 Results Denis Chem Lab Ltd announced a Board of Directors meeting scheduled for 13th Aug'26 to consider and approve the unaudited financial results for the quarter ended 30th Jun'26. The trading window for designated persons, which closed on 23rd Jun'26, will remain shut until 48 hours after the results are declared, in compliance with SEBI insider trading regulations.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for VS Holding BV
Acquisition/ Disposal of Shares · 01 Aug 2026, 11:38 pm
VS Holding BV Sells Stake in Denis Chem Lab VS Holding BV, a non-promoter entity, sold 285,845 shares (2.06% stake) of Denis Chem Lab Limited in open market transactions. The sale occurred in multiple tranches through Jul'26, concluding on 30 Jul'26. Following the sale, VS Holding BV's stake in the company decreased from 2,877,774 shares (20.74%) to 2,591,929 shares (18.68%). The total voting capital of Denis Chem Lab remained unchanged at 13,876,668 equity shares.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for VS Holding BV
Acquisition/ Disposal of Shares · 31 Jul 2026, 8:40 pm
VS Holding BV Sells Stake in Denis Chem Lab via Open Market VS Holding BV sold 285,845 equity shares, representing 2.06% of Denis Chem Lab Limited's total voting capital, through open market transactions. The sales occurred in multiple tranches up to 30 Jul'26. This transaction reduced VS Holding BV's stake in the company from 2,877,774 shares (20.74%) to 2,591,929 shares (18.68%). The acquirer is not part of the promoter group. The total voting capital of Denis Chem Lab remains unchanged at 13,876,668 shares.
The Board of Directors in their meeting held today reappointed Mr. Himanshu C. Patel as Managing Director of the Company for the period of 3 years with effect from 1st August, 2026 subject ....
Change in Management · 29 Jul 2026, 7:03 pm
Denis Chem Lab Reappoints Dr. Himanshu C. Patel as Managing Director Denis Chem Lab has reappointed Dr. Himanshu C. Patel as Managing Director for a three-year term, effective 01 Aug'26. This decision, made by the Board of Directors on 29 Jul'26, is subject to shareholder approval at the upcoming 45th AGM. Dr. Patel holds 2,048,137 equity shares in the company and has over four decades of experience in the medical and pharmaceutical fields. The reappointment ensures leadership continuity for the company.
Pursuant to regulation 42 of SEBI (LODR), Regulations, The Board of Directors in their meeting held today have fixed Friday, 18th September, 2026 as Record date for determining the members ....
Dividend · 29 Jul 2026, 6:56 pm
The Board of Directors in their meeting held today have Re-appointed Mr. Himanshu C. Patel as Managing Director of the Company for the period of 3 years with effect from 1st August, 2026 ....
Change in Management · 29 Jul 2026, 6:48 pm
Denis Chem Lab Sets AGM, Dividend Record Date, Re-appoints MD Denis Chem Lab has scheduled its 45th AGM for 25th Sep'26 via video conference. The Board has set 18th Sep'26 as the record date for determining shareholder eligibility for the FY26 final dividend, if declared. Additionally, the Board re-appointed Dr. Himanshu C. Patel as Managing Director for a three-year term effective 01st Aug'26, and appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for a five-year term starting from FY 2026-27, both subject to shareholder approval at the AGM.
Intimation regarding appointment of secretarial Auditor of the Company for the term of 5 year subject to approval of shareholders/ Members in ensuing Annual General Meeting.
Change in Management · 29 Jul 2026, 6:44 pm
The Board of Directors of the Company in their meeting held today decided the date of Board Meeting, Record date for Dividend, E-voting for AGM and other matters.
Annual General Meeting · 29 Jul 2026, 6:40 pm